Taro Pharmaceuticals   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Haifa Israel (1950)
Status: Acquired by Sun Pharmaceuticals (2010)

Organization Overview

First Clinical Trial
2005
NCT00244439
First Marketed Drug
1977
desoximetasone (topicort)
First NDA Approval
1977
desoximetasone (topicort)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ROACO | TARO | TARO PHARM | Taro Pharmaceuticals | Taro Pharmaceuticals Inc | Taro Pharmaceuticals, Inc. | Taro Pharmaceuticals USA | Taro Pharmaceuticals USA Inc. | TARO PHARMA USA INC | TARO PHARM INDS | TARO PHARM INDS LTD | TARO PHARMS | TARO PHARMS IRELAND | TARO PHARMS NORTH